Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.
2.

Clinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child HIV transmission.

Vardhanabhuti S, Acosta EP, Ribaudo HJ, Severe P, Lalloo U, Kumarasamy N, Taulo F, Kabanda J, Oneko O, Ive P, Sambarey P, Chan ES, Hitti J, Hong F, McMahon D, Haas DW; A5207 ACTG Study Team.

J Infect Dis. 2013 Aug 15;208(4):662-71. doi: 10.1093/infdis/jit223. Epub 2013 May 17.

3.

Clinical implications of HIV-1 minority variants.

Li JZ, Kuritzkes DR.

Clin Infect Dis. 2013 Jun;56(11):1667-74. doi: 10.1093/cid/cit125. Epub 2013 Feb 27.

4.

Standing genetic variation and the evolution of drug resistance in HIV.

Pennings PS.

PLoS Comput Biol. 2012;8(6):e1002527. doi: 10.1371/journal.pcbi.1002527. Epub 2012 Jun 7.

5.

A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine.

Van Dyke RB, Ngo-Giang-Huong N, Shapiro DE, Frenkel L, Britto P, Roongpisuthipong A, Beck IA, Yuthavisuthi P, Prommas S, Puthanakit T, Achalapong J, Chotivanich N, Rasri W, Cressey TR, Maupin R, Mirochnick M, Jourdain G; IMPAACT P1032 Protocol Team.

Clin Infect Dis. 2012 Jan 15;54(2):285-93. doi: 10.1093/cid/cir798. Epub 2011 Dec 5.

6.

Selection of HIV resistance associated with antiretroviral therapy initiated due to pregnancy and suspended postpartum.

Ellis GM, Huang S, Hitti J, Frenkel LM; P1022 Study Team.

J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):241-7. doi: 10.1097/QAI.0b013e31822b4edc.

7.

Emergence and persistence of minor drug-resistant HIV-1 variants in Ugandan women after nevirapine single-dose prophylaxis.

Hauser A, Mugenyi K, Kabasinguzi R, Kuecherer C, Harms G, Kunz A.

PLoS One. 2011;6(5):e20357. doi: 10.1371/journal.pone.0020357. Epub 2011 May 31.

8.

Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine.

Boltz VF, Zheng Y, Lockman S, Hong F, Halvas EK, McIntyre J, Currier JS, Chibowa MC, Kanyama C, Nair A, Owino-Ong'or W, Hughes M, Coffin JM, Mellors JW.

Proc Natl Acad Sci U S A. 2011 May 31;108(22):9202-7. doi: 10.1073/pnas.1105688108. Epub 2011 May 16.

9.

Addition of 7 days of zidovudine plus lamivudine to peripartum single-dose nevirapine effectively reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi.

Farr SL, Nelson JA, Ng'ombe TJ, Kourtis AP, Chasela C, Johnson JA, Kashuba AD, Tegha GL, Wiener J, Eron JJ, Banda HN, Mpaso M, Lipscomb J, Matiki C, Fiscus SA, Jamieson DJ, van der Horst C; BAN Study Team.

J Acquir Immune Defic Syndr. 2010 Aug;54(5):515-23. Erratum in: J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):e53.

Items per page

Supplemental Content

Write to the Help Desk